Fjarde AP Fonden Fourth Swedish National Pension Fund Sells 1,900 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fjarde AP Fonden Fourth Swedish National Pension Fund trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,979 shares of the medical equipment provider’s stock after selling 1,900 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Intuitive Surgical were worth $35,482,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of ISRG. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at about $26,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the third quarter valued at about $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at about $36,000. Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical during the third quarter valued at about $38,000. Finally, DT Investment Partners LLC raised its position in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

ISRG opened at $591.79 on Friday. The firm’s fifty day moving average is $565.45 and its two-hundred day moving average is $525.06. The firm has a market cap of $210.78 billion, a PE ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,348 shares of company stock worth $3,587,582. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on ISRG. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Leerink Partners increased their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.